GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

US and European stock markets stalled or trimmed gains on Friday after a bullish week buoyed by US data and upbeat company ...

European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

--In Europe, the Stoxx Europe 600 climbed 0.3% in morning trading. France's CAC 40 increased 0.4% and Germany's DAX rose 0.3%. Vestas Wind Systems added 11.6% after an upgrade. GSK lost over 6.0%, and ...

The fallers board was led by WPP, which slumped by 16% to its lowest level since 2009 after the marketing and advertising ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are ... which is more than double the S&P 500's performance over the same time frame. However, the ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, regulatory and pipeline successes and an optimistic outlook for the long term ...